LGM (Vena Tech) vena caval filter: experience at a single institution.
OBJECTIVE
The authors describe their experience with LG-Medical (LGM [Vena Tech]) filter placement and follow-up.


METHODS
LGM vena cava filters were placed in 63 patients. Follow-up was obtained by means of duplex sonography of the introduction vein and inferior vena cava (IVC) and abdominal radiography in 50 patients, and by means of autopsy in an additional four patients. In eight, only clinical follow-up was obtained and one patient was lost to follow-up.


RESULTS
Major complications of placement occurred in three patients, all when the right internal jugular vein was used for introduction: In one patient a filter was inadvertently placed in the right renal vein and in two the filter failed to open fully. No serious complications of placement occurred when either the right or left common femoral veins were used. Pulmonary embolism (PE) recurred in four patients (6%) and was fatal in one. Septicemia from an infected filter was the probable cause of death in another patient. Introduction vein thrombosis occurred in five patients (8%) and was symptomatic in two (3%). Occlusion of the IVC occurred in 15 patients (24% of the total patient group, but 28% of those with objective follow-up) and was symptomatic in 12 (19%). Two patients with IVC occlusion had recurrent PE.


CONCLUSIONS
These data suggest that the rate of IVC occlusion is higher than most previous reports have suggested and that IVC occlusion may be a potentially serious complication.
Millward
S F
SF
Department of Radiological Sciences, Ottawa Civic Hospital, Ontario, Canada.
Peterson
R A
RA
Moher
D
D
Lewandowski
B J
BJ
Burbridge
B E
BE
Aquino
J
J
Formoso
A
A
D004867:Equipment Design; D005260:Female; D005268:Femoral Vein; D005500:Follow-Up Studies; D006801:Humans; D007601:Jugular Veins; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000517:prevention & control*; D013927:Thrombosis / Q000453:epidemiology* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D016306:Vena Cava Filters / Q000009:adverse effects*; D014682:Vena Cava, Inferior